TRAITEMENT DE LA SCLÉROSE EN PLAQUES ET / OU DE LA POLYARTHRITE RHUMATOÏDE AVEC DES ANTICORPS ANTI-CCR2

• 收藏
• 分享

专利权人:

GEORG-AUGUST-UNIVERSITAET GOETTINGEN;KLINIKUM DER UNIVERSITAET REGENSBURG - ANSTALT DES OEFFENTLICHEN RECHTS-

发明人:

PRINZ, MARCO,BRUECK, WOLFGANG,MILDNER, ALEXANDER,MACK, MATTHIAS

申请号：

EP07723870.7

公开号：

EP2004692B1

申请日:

2007.04.02

申请国别(地区):

EP

年份:

2013

代理人:

摘要：

Use of an antibody, which specifically binds to the chemokine receptor (CCR) 2, for the production of a medicament for the treatment of multiple sclerosis and/or rheumatoid arthritis in the subject or which depletes the monocytes, for the production of a medicament for the treatment of multiple sclerosis or rheumatoid arthritis in a subject, is claimed. An independent claim is included for depletion of monocytes comprising contacting the monocytes with an antibody and excluding procedure that represents a surgical or therapeutic treatment of the human or animal body. ACTIVITY : Neuroprotective； Antiarthritic； Antirheumatic. MECHANISM OF ACTION : CCR2 binder.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/